aluates Reports

$ 0.0

Automative

Global Prophylactic HIV Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-7T7637

Global Prophylactic HIV Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Prophylactic HIV Drug Market Research Report 2025

Code: QYRE-Auto-7T7637

Report

September 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead Sciences

Merck

Mylan NV

Cipla Ltd

Bristol–Myers Squibb

Roche

Prophylactic HIV Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prophylactic HIV Drug Market

The global market for Prophylactic HIV Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become the chief contributor to the global burden diseases.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prophylactic HIV Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prophylactic HIV Drug.

The Prophylactic HIV Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prophylactic HIV Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prophylactic HIV Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prophylactic HIV Drug Market Report

Report Metric	Details
Report Name	Prophylactic HIV Drug Market
CAGR	5%
Segment by Type	Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Integrase Inhibitor
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Gilead Sciences, Merck, Mylan, Cipla, Bristol-Myers Squibb, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prophylactic HIV Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prophylactic HIV Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prophylactic HIV Drug Market report?

Ans: The main players in the Prophylactic HIV Drug Market are Gilead Sciences, Merck, Mylan, Cipla, Bristol-Myers Squibb, Roche

What are the Application segmentation covered in the Prophylactic HIV Drug Market report?

Ans: The Applications covered in the Prophylactic HIV Drug Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Prophylactic HIV Drug Market report?

Ans: The Types covered in the Prophylactic HIV Drug Market report are Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI), Integrase Inhibitor

Recommended Reports

HIV & Antiviral Drugs

Diagnostics & Testing

Vaccines & Therapeutics

1 Prophylactic HIV Drug Market Overview

1.1 Product Definition

1.2 Prophylactic HIV Drug by Type

1.2.1 Global Prophylactic HIV Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)

1.2.3 Integrase Inhibitor

1.3 Prophylactic HIV Drug by Application

1.3.1 Global Prophylactic HIV Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Prophylactic HIV Drug Market Size Estimates and Forecasts

1.4.1 Global Prophylactic HIV Drug Revenue 2020-2031

1.4.2 Global Prophylactic HIV Drug Sales 2020-2031

1.4.3 Global Prophylactic HIV Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Prophylactic HIV Drug Market Competition by Manufacturers

2.1 Global Prophylactic HIV Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Prophylactic HIV Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Prophylactic HIV Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Prophylactic HIV Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Prophylactic HIV Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Prophylactic HIV Drug, Product Type & Application

2.7 Global Key Manufacturers of Prophylactic HIV Drug, Date of Enter into This Industry

2.8 Global Prophylactic HIV Drug Market Competitive Situation and Trends

2.8.1 Global Prophylactic HIV Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Prophylactic HIV Drug Players Market Share by Revenue

2.8.3 Global Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Prophylactic HIV Drug Market Scenario by Region

3.1 Global Prophylactic HIV Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Prophylactic HIV Drug Sales by Region: 2020-2031

3.2.1 Global Prophylactic HIV Drug Sales by Region: 2020-2025

3.2.2 Global Prophylactic HIV Drug Sales by Region: 2026-2031

3.3 Global Prophylactic HIV Drug Revenue by Region: 2020-2031

3.3.1 Global Prophylactic HIV Drug Revenue by Region: 2020-2025

3.3.2 Global Prophylactic HIV Drug Revenue by Region: 2026-2031

3.4 North America Prophylactic HIV Drug Market Facts & Figures by Country

3.4.1 North America Prophylactic HIV Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Prophylactic HIV Drug Sales by Country (2020-2031)

3.4.3 North America Prophylactic HIV Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Prophylactic HIV Drug Market Facts & Figures by Country

3.5.1 Europe Prophylactic HIV Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Prophylactic HIV Drug Sales by Country (2020-2031)

3.5.3 Europe Prophylactic HIV Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prophylactic HIV Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Prophylactic HIV Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Prophylactic HIV Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Prophylactic HIV Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Prophylactic HIV Drug Market Facts & Figures by Country

3.7.1 Latin America Prophylactic HIV Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Prophylactic HIV Drug Sales by Country (2020-2031)

3.7.3 Latin America Prophylactic HIV Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prophylactic HIV Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Prophylactic HIV Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Prophylactic HIV Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Prophylactic HIV Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Prophylactic HIV Drug Sales by Type (2020-2031)

4.1.1 Global Prophylactic HIV Drug Sales by Type (2020-2025)

4.1.2 Global Prophylactic HIV Drug Sales by Type (2026-2031)

4.1.3 Global Prophylactic HIV Drug Sales Market Share by Type (2020-2031)

4.2 Global Prophylactic HIV Drug Revenue by Type (2020-2031)

4.2.1 Global Prophylactic HIV Drug Revenue by Type (2020-2025)

4.2.2 Global Prophylactic HIV Drug Revenue by Type (2026-2031)

4.2.3 Global Prophylactic HIV Drug Revenue Market Share by Type (2020-2031)

4.3 Global Prophylactic HIV Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Prophylactic HIV Drug Sales by Application (2020-2031)

5.1.1 Global Prophylactic HIV Drug Sales by Application (2020-2025)

5.1.2 Global Prophylactic HIV Drug Sales by Application (2026-2031)

5.1.3 Global Prophylactic HIV Drug Sales Market Share by Application (2020-2031)

5.2 Global Prophylactic HIV Drug Revenue by Application (2020-2031)

5.2.1 Global Prophylactic HIV Drug Revenue by Application (2020-2025)

5.2.2 Global Prophylactic HIV Drug Revenue by Application (2026-2031)

5.2.3 Global Prophylactic HIV Drug Revenue Market Share by Application (2020-2031)

5.3 Global Prophylactic HIV Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Gilead Sciences

6.1.1 Gilead Sciences Company Information

6.1.2 Gilead Sciences Description and Business Overview

6.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Gilead Sciences Prophylactic HIV Drug Product Portfolio

6.1.5 Gilead Sciences Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Prophylactic HIV Drug Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Mylan

6.3.1 Mylan Company Information

6.3.2 Mylan Description and Business Overview

6.3.3 Mylan Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Mylan Prophylactic HIV Drug Product Portfolio

6.3.5 Mylan Recent Developments/Updates

6.4 Cipla

6.4.1 Cipla Company Information

6.4.2 Cipla Description and Business Overview

6.4.3 Cipla Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cipla Prophylactic HIV Drug Product Portfolio

6.4.5 Cipla Recent Developments/Updates

6.5 Bristol-Myers Squibb

6.5.1 Bristol-Myers Squibb Company Information

6.5.2 Bristol-Myers Squibb Description and Business Overview

6.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Product Portfolio

6.5.5 Bristol-Myers Squibb Recent Developments/Updates

6.6 Roche

6.6.1 Roche Company Information

6.6.2 Roche Description and Business Overview

6.6.3 Roche Prophylactic HIV Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Roche Prophylactic HIV Drug Product Portfolio

6.6.5 Roche Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Prophylactic HIV Drug Industry Chain Analysis

7.2 Prophylactic HIV Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prophylactic HIV Drug Production Mode & Process Analysis

7.4 Prophylactic HIV Drug Sales and Marketing

7.4.1 Prophylactic HIV Drug Sales Channels

7.4.2 Prophylactic HIV Drug Distributors

7.5 Prophylactic HIV Drug Customer Analysis

8 Prophylactic HIV Drug Market Dynamics

8.1 Prophylactic HIV Drug Industry Trends

8.2 Prophylactic HIV Drug Market Drivers

8.3 Prophylactic HIV Drug Market Challenges

8.4 Prophylactic HIV Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Gilead Sciences

Merck

Mylan NV

Cipla Ltd

Bristol–Myers Squibb

Roche

List of Tables

Table 1. Global Prophylactic HIV Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Prophylactic HIV Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Prophylactic HIV Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Prophylactic HIV Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Prophylactic HIV Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Prophylactic HIV Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Prophylactic HIV Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Prophylactic HIV Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Prophylactic HIV Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Prophylactic HIV Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Prophylactic HIV Drug, Product Type & Application

Table 12. Global Key Manufacturers of Prophylactic HIV Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Prophylactic HIV Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic HIV Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Prophylactic HIV Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Prophylactic HIV Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Prophylactic HIV Drug Sales Market Share by Region (2020-2025)

Table 19. Global Prophylactic HIV Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Prophylactic HIV Drug Sales Market Share by Region (2026-2031)

Table 21. Global Prophylactic HIV Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Prophylactic HIV Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Prophylactic HIV Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Prophylactic HIV Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Prophylactic HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Prophylactic HIV Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Prophylactic HIV Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Prophylactic HIV Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Prophylactic HIV Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Prophylactic HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Prophylactic HIV Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Prophylactic HIV Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Prophylactic HIV Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Prophylactic HIV Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Prophylactic HIV Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Prophylactic HIV Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Prophylactic HIV Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Prophylactic HIV Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Prophylactic HIV Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prophylactic HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Prophylactic HIV Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Prophylactic HIV Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Prophylactic HIV Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Prophylactic HIV Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Prophylactic HIV Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Prophylactic HIV Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Prophylactic HIV Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Prophylactic HIV Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Prophylactic HIV Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Prophylactic HIV Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Prophylactic HIV Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Prophylactic HIV Drug Sales Market Share by Type (2020-2025)

Table 53. Global Prophylactic HIV Drug Sales Market Share by Type (2026-2031)

Table 54. Global Prophylactic HIV Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Prophylactic HIV Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Prophylactic HIV Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Prophylactic HIV Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Prophylactic HIV Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Prophylactic HIV Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Prophylactic HIV Drug Sales Market Share by Application (2020-2025)

Table 63. Global Prophylactic HIV Drug Sales Market Share by Application (2026-2031)

Table 64. Global Prophylactic HIV Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Prophylactic HIV Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Prophylactic HIV Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Prophylactic HIV Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2026-2031)

Table 70. Gilead Sciences Company Information

Table 71. Gilead Sciences Description and Business Overview

Table 72. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Gilead Sciences Prophylactic HIV Drug Product

Table 74. Gilead Sciences Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Merck Prophylactic HIV Drug Product

Table 79. Merck Recent Developments/Updates

Table 80. Mylan Company Information

Table 81. Mylan Description and Business Overview

Table 82. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Mylan Prophylactic HIV Drug Product

Table 84. Mylan Recent Developments/Updates

Table 85. Cipla Company Information

Table 86. Cipla Description and Business Overview

Table 87. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Cipla Prophylactic HIV Drug Product

Table 89. Cipla Recent Developments/Updates

Table 90. Bristol-Myers Squibb Company Information

Table 91. Bristol-Myers Squibb Description and Business Overview

Table 92. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Bristol-Myers Squibb Prophylactic HIV Drug Product

Table 94. Bristol-Myers Squibb Recent Developments/Updates

Table 95. Roche Company Information

Table 96. Roche Description and Business Overview

Table 97. Roche Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Roche Prophylactic HIV Drug Product

Table 99. Roche Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Prophylactic HIV Drug Distributors List

Table 103. Prophylactic HIV Drug Customers List

Table 104. Prophylactic HIV Drug Market Trends

Table 105. Prophylactic HIV Drug Market Drivers

Table 106. Prophylactic HIV Drug Market Challenges

Table 107. Prophylactic HIV Drug Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Prophylactic HIV Drug

Figure 2. Global Prophylactic HIV Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prophylactic HIV Drug Market Share by Type: 2024 & 2031

Figure 4. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Product Picture

Figure 5. Integrase Inhibitor Product Picture

Figure 6. Global Prophylactic HIV Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Prophylactic HIV Drug Market Share by Application: 2024 & 2031

Figure 8. Hospital Pharmacy

Figure 9. Retail Pharmacy

Figure 10. Online Pharmacy

Figure 11. Global Prophylactic HIV Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Prophylactic HIV Drug Market Size (2020-2031) & (US$ Million)

Figure 13. Global Prophylactic HIV Drug Sales (2020-2031) & (K Units)

Figure 14. Global Prophylactic HIV Drug Average Price (USD/Unit) & (2020-2031)

Figure 15. Prophylactic HIV Drug Report Years Considered

Figure 16. Prophylactic HIV Drug Sales Share by Manufacturers in 2024

Figure 17. Global Prophylactic HIV Drug Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Prophylactic HIV Drug Players: Market Share by Revenue in Prophylactic HIV Drug in 2024

Figure 19. Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Prophylactic HIV Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Prophylactic HIV Drug Sales Market Share by Country (2020-2031)

Figure 22. North America Prophylactic HIV Drug Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Prophylactic HIV Drug Sales Market Share by Country (2020-2031)

Figure 26. Europe Prophylactic HIV Drug Revenue Market Share by Country (2020-2031)

Figure 27. Germany Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Prophylactic HIV Drug Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Prophylactic HIV Drug Revenue Market Share by Region (2020-2031)

Figure 34. China Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Prophylactic HIV Drug Sales Market Share by Country (2020-2031)

Figure 45. Latin America Prophylactic HIV Drug Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Prophylactic HIV Drug Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Prophylactic HIV Drug Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Prophylactic HIV Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Prophylactic HIV Drug by Type (2020-2031)

Figure 55. Global Revenue Market Share of Prophylactic HIV Drug by Type (2020-2031)

Figure 56. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Prophylactic HIV Drug by Application (2020-2031)

Figure 58. Global Revenue Market Share of Prophylactic HIV Drug by Application (2020-2031)

Figure 59. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2020-2031)

Figure 60. Prophylactic HIV Drug Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prophylactic Ebola Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preventive Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti AIDs Drug Market Insights Forecast to 2030

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Vaccine Market Research Report 2025

Global HIV Clinical Trials Market Research Report 2025

Pediatric HIV Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prophylaxis Powder Market Research Report 2024

Global Long acting Anti HIV Drug Market Research Report 2024

Global HIV Antiretroviral Drug Market Research Report 2025

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV and AIDS Clinical Trials Market Research Report 2025

Global HIV Therapy Drug Market Research Report 2025

Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV and AIDS Vaccine Market Research Report 2024

Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV 1 Screening Tests Market Research Report 2025

Dental Infection Prevention Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions